Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
9.06
+0.02 (0.22%)
Apr 24, 2025, 4:08 PM HKT
HKG:1858 Revenue
In the year 2024, Beijing Chunlizhengda Medical Instruments had annual revenue of 805.86M CNY, down -33.32%. Beijing Chunlizhengda Medical Instruments had revenue of 297.57M in the quarter ending December 31, 2024, a decrease of -28.53%.
Revenue
805.86M CNY
Revenue Growth
-33.32%
P/S Ratio
5.99
Revenue / Employee
651.46K CNY
Employees
1,237
Market Cap
5.14B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 805.86M | -402.67M | -33.32% |
Dec 31, 2023 | 1.21B | 6.92M | 0.58% |
Dec 31, 2022 | 1.20B | 93.46M | 8.43% |
Dec 31, 2021 | 1.11B | 170.45M | 18.18% |
Dec 31, 2020 | 937.69M | 82.36M | 9.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
CSPC Pharmaceutical Group | 30.87B |